Common buying and selling questions

Does an NDA let a buyer access patient records?

An NDA alone does not let a buyer access patient records. It sets contractual confidentiality duties, while lawful disclosure depends on the records, parties, purpose and applicable rules. Review each proposed access path and reassess it when the requested detail, recipient or use changes during the sale.

Rules current as of September 2026 — verify with the licensing agency. This educational review is limited to the issues and sources identified below.

Book a confidential intro call

Jason Taken · HedgeStone Business Advisors

Jump to a section

Key takeaways

  • A confidentiality signature and lawful records access answer different questions.
  • Earlier permission for a limited review does not settle a later, broader request.
  • Use qualified privacy review and record what the evidence can actually support.

Short answer

Start with the buyer’s decision, not a request to open every folder. Ask what fact needs verification and what information could answer it. A review of revenue trends differs from a clinical review or a test of historical billing. Identify the record holder, intended user and task before preparing the file.

The NDA definition explains the contract’s commercial role. The records-custody guide covers storage and handoff. This answer focuses on a narrower issue: an approved review can change as the buyer adds people, details or new uses.

Longer answer

HIPAA’s definition of health care operations includes certain sales, transfers, mergers and related diligence. It concerns a covered entity and another covered entity, or an entity that will become covered through that activity. Section 164.506 also addresses permitted uses and disclosures subject to its other requirements. Those provisions do not give every interested buyer unrestricted chart access. (Source: GPO Title 45, sections 164.501 and 164.506; 14 MB XML download)

The responsible privacy adviser must assess the actual transaction and information. Other laws and special record categories may matter. A nonmedical service business is not automatically a HIPAA covered entity merely because it serves older adults. Equally, records outside HIPAA may still have legal or contractual protections.

HHS’s minimum-necessary guidance describes reasonable limits for covered uses, requests and disclosures, with express exceptions. It also distinguishes routine protocols from individual review of non-routine requests. The team should apply the actual standard rather than assume that every request follows one rule. (Source: HHS minimum necessary)

For a qualifying business associate relationship, HHS describes written assurances and restrictions on permitted uses. Status depends on the functions and services involved, including relevant subcontractors. An investor, clinical consultant and storage provider should not be treated as interchangeable merely because each signed something confidential. (Source: HHS business associates)

What it depends on

Record the original request in plain language. Name the question, approved recipients, information level, purpose and review method. Keep the responsible person’s decision with that request. If the buyer later asks for more, compare the new request with those facts before expanding access.

A new recipient can create a new issue even if the file is unchanged. A new use can do the same. For example, information prepared for a specific diligence task should not be treated as available for a buyer’s unrelated product development. The relevant agreements and law need their own assessment of that use.

The contents also matter. HHS explains two HIPAA de-identification methods: Expert Determination and Safe Harbor. Names are only part of the issue; other details or combinations may identify someone. Do not assume a coded file is suitable for broad release. (Source: HHS de-identification)

Keep the business question visible through the diligence checklist. A quality-of-earnings review may need evidence about reported revenue, but the report should explain what was checked and what access limits remain. A strong financial label does not establish lawful chart access.

Example

Assume a fictional seller’s team has approved a limited summary for a defined financial review. No patient-level access has been approved. The buyer then submits the three requests below. The example identifies changes to review; it does not decide that any proposed disclosure is lawful or unlawful.

Later fictional requestWhat changedWhat the team must reassess
Add complete care charts behind the summaryLevel and type of informationActual need, lawful route and scope of records
Give a new consulting company accessRecipient and its roleIdentity, task, relationship and required protections
Keep the information for a separate analytics projectPurpose and future useWhether that use has an applicable basis and permitted terms

Each request is different even though the NDA has not changed. The team should record each difference and route it to the proper reviewer. It may approve an appropriately supported method, ask for a narrower request or leave the question open. The fictional summary approval does not determine the next result.

The data-room guide explains why access settings should match that decision. Do not create a general login while a request is unresolved and expect the recipient to infer which records are off limits. Keep the decision and actual permissions aligned.

The NDA access-register guide develops the next step: compare the exact export and active users with the approved request. It also separates closing a room account from resolving copies retained outside the room.

What to do next

Use the seller document guide to identify the available evidence and the confidential sale guide to coordinate requests. Bring the exact parties, purpose and proposed fields to the privacy adviser before changing access.

Record the result, its limits and the conditions that would require another review. At handoff, the first 90 days guide helps separate buyer diligence from the authorized operator’s ongoing work. A transaction milestone does not turn every earlier request into permission.

Frequently asked questions

Does calling a file anonymous establish de-identification?

No. HHS describes Expert Determination and Safe Harbor as HIPAA methods. Removing names, adding codes or using a reassuring filename does not establish that the standard is met. Review the remaining information and any other facts that could connect it to a person.

Does every buyer or adviser need the same BAA?

No single answer fits every role. Business associate status depends on the work and relationship involving protected information. Have the actual parties and services reviewed. A BAA addresses a qualifying relationship; it is not a substitute for identifying a permitted disclosure purpose and applicable limits.

Does view-only access avoid the need for a privacy review?

No. Viewing information still requires the applicable authority and safeguards. A tool setting does not establish that the person should see the record. Review the requested access and the platform’s actual controls; a restriction on downloading is not a general permission to disclose.

What if the limited evidence cannot answer the buyer’s question?

State that limit clearly. The team can assess a more focused review or another lawful source of evidence. Do not label an unanswered question verified merely because full records cannot be shared. Access limits and the strength of the resulting conclusion belong in the review report.

Sources

Sources are dated to distinguish current guidance from earlier publications. They support the identified facts; the transaction questions and examples are educational analysis.

  1. GPO current Title 45: health care operations and permitted uses (14 MB XML download) (2026). Retrieved September 8, 2026.
  2. HHS: minimum necessary requirement (2003). Retrieved September 5, 2026.
  3. HHS: business associates (2026). Retrieved September 5, 2026.
  4. HHS: de-identification guidance (2026). Retrieved September 5, 2026.
Jason Taken

Business broker · HedgeStone Business Advisors
jason.taken@hedgestone.com

AI-assisted educational content. Research methods and editorial standards. Published September 8, 2026.

A conversation, at your pace

Make an informed next move.

Talk with Jason Taken about your business, your plans, and the issues to resolve before a transaction.

Schedule your introduction with Jason